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Introduction
The predominant structural lesions of the heart in elderly are the valvular and annular 
degenerative lesions, which are commonly detected by echocardiography [1]. Mitral annular 
calcification is one of the most common cardiac abnormalities in elderly patients. It is found in 
about 8.5% to 12.5% of elderly patients [2]. On the other hand, calcification of the aortic valve 
was seen in 40% of American elderly [3]. In England aortic valve calcification affects 21-26% of 
elderly over 65 years of age [4]. Inspite of the increase in prevalence of valvular calcification 
with aging; the cause of age related degenerative valvular calcifications is largely unknown [5]. 
Some authors found that the atherosclerotic risk factors may have a role in degenerative 
calcification of cardiac valves [6-11]. Others proposed that disturbed calcium phosphorus ratio 
and the elevated level of parathyroid hormone which occurs in elderly may be of value [12-15]. 
Tenenbaum et al. (2002) [16] concluded that there is a relation between valvular calcification and 
osteoporosis. Both may share the same etiology. So this study was done to evaluate the risk 
factors of degenerative calcification of cardiac valves in the elderly. 
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CLINICAL STUDIES 
Abstract: The underlying cause of age related degenerative valvular calcifications is largely unknown. As a 
result, a case control study was used to evaluate the hypothesized risk factors. One hundred seventy two 
elderly matched for age & gender participated in this study (86 cases & 86 matched controls). Assessment of 
risk factors for atherosclerosis was done with medical history as well as measurement of body mass index 
(BMI), blood sugar, lipid profile, and homocysteine. Measurement of bone minerals, parathyroid hormone 
(PTH) and bone mass density (BMD) were also done. This study confirmed the vascular hypothesis of 
degenerative calcification of cardiac valves. It showed that with multiple logistic regression analysis, the 
magnitude of the risk conveyed by atherosclerotic risk factors was particularly high for high cholesterol 
level, low HDL level, high LDL level & high homocysteine level. Those factors were independent risk 
factors for degenerative calcification of cardiac valves (P = 0.019).
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Subjects and Methods
A case control study was used to evaluate the hypothesized risk factors for degenerative 
calcification of cardiac valves in elderly. The study was conducted on 86 elderly (aged 60 years 
or more) with degenerative calcification of cardiac valves compared with 86 controls with no 
evidence of the lesion detected by echocardiography. Both cases and controls were selected 
from Geriatric department, Ain Shams University hospital to be cross matched regarding age, 
gender, physical, psychological and medical problems. Patients with rheumatic heart disease, 
prosthetic valves, congenital heart disease, patients on haemodialysis, patients with liver cell 
failure, and patients with cerebrovascular stroke were excluded. Thorough medical history and 
clinical examination were done including detailed history of smoking, diabetes, hypertension 
and ischemic heart disease. Hypertension was defined as a setting blood pressure  14090 in
kilograms / height in meters2. The atherosclerotic risk factors considered in this study were 
presence of diabetes mellitus, hypertension, hyperlipidaemia, high homocysteine level, obesity, 
and smoking. Diabetes mellitus was defined as fasting blood sugar  126 mg/dl and 
postprandial blood sugar  200 mg/dl [17], or if diabetes mellitus had been verified earlier. 
Hypercholesterolemia was defined as a total cholesterol level of  200 mg/dl. 
Hypertriglyceridemia was defined as a total TG level  150 mg/dl. High LDL level was defined 
as a total LDL level  130 mg/dl. Low HDL level was defined as a HDL level  40 mg/dl. 
High homocysteine level was defined as homocysteine level > 20 u mol/liter [18]. Twelve leads 
electrocardiography was done for each participant for detection of evidence of ischemic heart 
diseases or myocardial infarction. 
Transthoracic echocardiography (M-mode, two dimensional and Doppler
echocardiography) was done at the Echocardiography Unit, Cardiology department for each 
participant using a Vivid Five GE (Ving. Med. Technology) Pro Configuration with a 2.5 MHz 
imaging and Doppler transducer to assess the presence of degenerative calcification of aortic or 
mitral valve and to detect of evidence of ischemic heart diseases.
Echocardiographic data were analyzed by cardiologist who was blinded to clinical data 
of patients. Bone mineral density as determined from lumbar spine, left forearm, & left neck 
femur was measured for each participants by the use of (LUNAR DPX- MD+) apparatus 
present in osteoporosis unit geriatric department Ain Shams University Hospital. Osteoporosis 
was defined as T-score  -2.5 [20]. Fourteen to sixteen ml venous blood samples were taken 
under certain precautions; without tourniquet application. Samples were allowed to clot for no 
more than 30 minutes, and then for separation of serum centrifuged. Serum total cholesterol, 
LDL, HDL & triglycerides concentrations, serum glucose, calcium, phosphorus & creatinine 
were measured enzymatically (Boehringer Mannheim, Germany) using standard laboratory
methods in an automatic analyzer (Synchron CX 5). PTH & homocysteine were measured using 
ELISA assays using commercial kits purchased from Diagnostic Products, CA, and USA.
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Statistical Methods
Data was analyzed using the 9th version of SPSS (Statistical Package for Social Science). 
The results were presented as mean ± SD for normally distributed data. Categorical data were 
compared between groups by Ȥ2 test. Continuous data were compared between groups using 
unpaired t test for normally distributed variables. Logistic regression was used for multivariate 
analysis. The multiple logistic regression coefficients were calculated by the maximum 
likelihood method. These coefficients describe the independent relationships between 
continuous explanatory and categorical dependant variables. They can be used for calculation of 
probabilities of different levels of the dependent variable. Significance was taken at the 5% 
level. 
Results
Table 1: Mean (±S.D) and percentage of the baseline clinical characteristics
Characters Cases (N=86) Controls (N=86) P
Age : (years)** 60-90 (68.0±5.5) 60-89 (67.4±5.7) >0.05
Women (%)* 48 (56%) 48 (56%) >0.05
Smokers (%)* 16 (19%) 20 (23%) > 0.05
BMI** 27.5±7.6 28.8±7.2 >0.05
Hypertensive (%)* 52 (60.5%) 20 (23%) <0.001
Diabetic (%)* 52 (60.5%) 12 (14%) <0.001
Patient with IHD (%) * 58 (67%) 8 (9%) <0.05
High cholesterol (%)* 68 (79%) 12 (14%) <0.001
High Triglycerides (%)* 18 (21%) 17 (19.8%) > 0.05
High LDL (%)* 16 (18.6%) 6 (7%) <0.001
Low HDL (%)* 15 (17.4%) 6 (7%) <0.001
High Homocysteine (%)* 61 (70.9%) 21 (24.4%) <0.001
Calcium (mg/dl)** 9.3±0.8 9.5±0.8 >0.05
Phosphorus (mg/dl)** 4.5±0.6 4.0±0.5 <0.001
Ca – ph Product 38.3±7.2 32.3±5.3 <0.001
High PTH (%)* 44 (51.2%) 12 (14%) <0.001
Osteoporosis (% )*
(T-score  -2.5)
71 (82.6%) 14 (16.3%) <0.001
            High PTH >60 pg/ml. Normal serum calcium was 8.4-10.2 mg/dl. Normal serum phosphorus was 2.5-4.6 mg/dl. 
                     Normal serum creatinine was 0.4-1.4 mg/dl. 6tatistical comparison E\ Ȥ2 test* or unpaired t-test.** 
In this study, it was found that the correlation coefficient between the 4 variables 
(cholesterol, LDL, HDL and homocysteine) was large and significant and introducing those 4
variables together in regression analysis distorted the model. So it was decided to develop an 
integrated variable from the 4 variables.
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Table 2: Pearson correlation between the integrated variable & “Cholesterol, LDL, HDL, Homocysteine”
Cholesterol LDL HDL Homocysteine
Pearson correlation 0.846* 0.718* -0.691* 0.855*
            *Highly significant correlation
Table 3: Multivariate logistic regression analysis of the independent risk factors for degenerative
calcification of cardiac valves
Variables Odds
Ratio
Confidence Interval P Value
Hypertension 0.429 0.98 – 1.05 0.604
Diabetes 0.392 0.738 – 1.02 0.648
Integrated variable 1.804 1.3 - 2.5 0.019*
Previous angina 0.939 0.809 – 1.09 0.4078
Phosphorus -0.118 0.23 – 0.63 0.120
Calcium - phosphorus 0.048 0.85 – 1.199 0.260
PTH 3.511 0.702 – 1.008 0.702
Osteoporosis -7.938 0.795 – 1.06 0.171
* Significant association
Discussion
This study confirmed the vascular hypothesis of degenerative calcification of cardiac 
valves. It showed that with multiple logistic regression analysis, the magnitude of the risk 
conveyed by atherosclerotic risk factors was particularly high for high cholesterol level, low 
HDL level, high LDL level and high homocysteine level. Those factors were independent risk 
factors for degenerative calcification of cardiac valves. While other significant factors detected 
by bivariate analysis were most probably associating factors with hyperlipidaemia not with 
degenerative calcification of cardiac valves. That is to say, their presence may be due the 
presence of hyperlipidaemia. Or it may be due to the large number of factors studied causing 
bias appeared in bivariate analysis.
Vascular hypothesis was based on several lines of evidence including: (1) Cardiac 
valves consist of leaflets of collagenous tissue their surface being invested with a thin 
endothelial layer continuous with that of the heart chambers and great vessels [21]. (2) The 
similarities between early lesions of cardiac valves and atherosclerotic process like cholesterol 
deposits, smooth cell proliferation, fibrosis and dystrophic calcification. [7, 22-24].
Ngo et al [25] explained the role of cholesterol in the development of degenerative 
calcification of cardiac valves. It shares in the built up of calcification with LDL & a triggering 
response from oxygen free radicals. In response to this process the immune system sends white 
blood cells to fight this new threat. Unfortunately, the result of the combination of blood cells 
and the oxidized cholesterol is a fatty plaque that damages the walls of cardiac valves. 
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Also the role of homocysteine was explained by Graber et al [26], Panganamala et al [27],
O’Brien et al [28]  (1996), Guthikonda & Haynes [29] and Khajuria & Houston [30], it is a highly 
reactive amino acid; it is toxic to vascular endothelium. It causes endothelial dysfunction and 
promotes vascular smooth muscle growth. It potentiates the auto – oxidation of LDL. 
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